High mobility group box 1 complexed with heparin induced angiogenesis in a matrigel plug assay.

Angiogenesis involves complex processes mediated by several factors and is associated with inflammation and wound healing. High mobility group box 1 (HMGB1) is released from necrotic cells as well as macrophages and plays proinflammatory roles. In the present study, we examined whether HMGB1 would exhibit angiogenic activity in a matrigel plug assay in mice. HMGB1 in combination with heparin strongly induced angiogenesis, whereas neither HMGB1 nor heparin alone showed such angiogenic activity. The heparin-dependent induction of angiogenesis by HMGB1 was accompanied by increases in the expression of tumor necrosis factor-alpha (TNF-alpha) and vascular endothelial growth factor-A120 (VEGF-A120). It is likely that the dependence of the angiogenic activity of HMGB1 on heparin was due to the efficiency of the diffusion of the HMGB1-heparin complex from matrigel to the surrounding areas. VEGF-A165 possessing a heparin-binding domain showed a pattern of heparin-dependent angiogenic activity similar to that of HMGB1. The presence of heparin also inhibited the degradation of HMGB1 by plasmin in vitro. Taken together, these results suggested that HMGB1 in complex with heparin possesses remarkable angiogenic activity, probably through the induction of TNF-alpha and VEGF-A120.

[1]  N. Van Rooijen,et al.  Extratumoral macrophages promote tumor and vascular growth in an orthotopic rat prostate tumor model. , 2009, Neoplasia.

[2]  E. Ruokonen,et al.  HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis , 2008, Intensive Care Medicine.

[3]  S. Sela,et al.  Are primed polymorphonuclear leukocytes contributors to the high heparanase levels in hemodialysis patients? , 2008, American journal of physiology. Heart and circulatory physiology.

[4]  T. Yoshino,et al.  Anti‐high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  A. Maseri,et al.  Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  K. Tracey,et al.  HMGB1 SIGNALS THROUGH TOLL-LIKE RECEPTOR (TLR) 4 AND TLR2 , 2006, Shock.

[7]  M. Presta.  Response to Comment on “Cutting Edge: Extracellular High Mobility Group Box-1 Protein Is a Proangiogenic Cytokine” , 2006, The Journal of Immunology.

[8]  M. Presta,et al.  Cutting Edge: Extracellular High Mobility Group Box-1 Protein Is a Proangiogenic Cytokine1 , 2006, The Journal of Immunology.

[9]  P. Rogalla,et al.  Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule. , 2005, The American journal of pathology.

[10]  Bart Landuyt,et al.  Vascular Endothelial Growth Factor and Angiogenesis , 2004, Pharmacological Reviews.

[11]  K. Tracey,et al.  Recombinant HMGB1 with cytokine-stimulating activity. , 2004, Journal of immunological methods.

[12]  M. Flugelman,et al.  Heparanase Induces Endothelial Cell Migration via Protein Kinase B/Akt Activation* , 2004, Journal of Biological Chemistry.

[13]  F. Yuan,et al.  Evidence for Involvement of HMGB1 Protein in Human DNA Mismatch Repair* , 2004, Journal of Biological Chemistry.

[14]  T. Sasahira,et al.  Depletion of Tumor-Infiltrating Macrophages Is Associated with Amphoterin Expression in Colon Cancer , 2004, Pathobiology.

[15]  M. Bianchi,et al.  Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation , 2004, The Journal of cell biology.

[16]  H. Kuniyasu,et al.  Differential effects between amphoterin and advanced glycation end products on colon cancer cells , 2003, International journal of cancer.

[17]  Hoguen Kim,et al.  Overexpression of high mobility group box 1 in gastrointestinal stromal tumors with KIT mutation. , 2003, Cancer research.

[18]  M. Yamakuchi,et al.  High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. , 2003, Arthritis and rheumatism.

[19]  K. Tracey,et al.  Activation of gene expression in human neutrophils by high mobility group box 1 protein. , 2003, American journal of physiology. Cell physiology.

[20]  K. Tracey,et al.  HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. , 2002, Gastroenterology.

[21]  A. Ridley,et al.  Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. , 2002, Cancer research.

[22]  T. Misteli,et al.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.

[23]  K. Tracey,et al.  HMGB1 as a late mediator of lethal systemic inflammation. , 2001, American journal of respiratory and critical care medicine.

[24]  M. Kaksonen,et al.  Heparin-binding proteins HB-GAM (pleiotrophin) and amphoterin in the regulation of cell motility. , 2000, Matrix biology : journal of the International Society for Matrix Biology.

[25]  K. Tracey,et al.  High Mobility Group 1 Protein (Hmg-1) Stimulates Proinflammatory Cytokine Synthesis in Human Monocytes , 2000, The Journal of experimental medicine.

[26]  T. Kislinger,et al.  Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases , 2000, Nature.

[27]  Michael Bustin,et al.  Regulation of DNA-Dependent Activities by the Functional Motifs of the High-Mobility-Group Chromosomal Proteins , 1999, Molecular and Cellular Biology.

[28]  K. Tracey,et al.  HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.

[29]  M. Schachner,et al.  High Affinity Binding and Overlapping Localization of Neurocan and Phosphacan/Protein-tyrosine Phosphatase-ζ/β with Tenascin-R, Amphoterin, and the Heparin-binding Growth-associated Molecule* , 1998, The Journal of Biological Chemistry.

[30]  N. Yoshimura,et al.  Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo , 1997, British journal of pharmacology.

[31]  T. Shono,et al.  Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis , 1997, Molecular and cellular biology.

[32]  K. Sugimachi,et al.  Enhanced coexpression of thioredoxin and high mobility group protein 1 genes in human hepatocellular carcinoma and the possible association with decreased sensitivity to cisplatin. , 1996, Cancer research.

[33]  G. Camussi,et al.  Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis , 1994, The Journal of experimental medicine.

[34]  H. Rauvala,et al.  Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation. , 1993, The Journal of biological chemistry.

[35]  A. Logan,et al.  Angiogenesis , 1993, The Lancet.

[36]  Wagner V. Yotov,et al.  Nucleotide sequence of a mouse cDNA encoding the nonhistone chromosomal high mobility group protein-1 (HMG1) , 1992, Nucleic Acids Res..

[37]  P. Colville-Nash,et al.  Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications. , 1992, Annals of the rheumatic diseases.

[38]  H. Rauvala,et al.  Neurite growth-promoting protein (amphoterin, p30) binds syndecan. , 1992, Experimental cell research.

[39]  G. Laurie,et al.  Basement membrane complexes with biological activity. , 1986, Biochemistry.

[40]  E. Mayes,et al.  The primary structures of non‐histone chromosomal proteins HMG 1 and 2 , 1980, FEBS letters.

[41]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[42]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[43]  Arjan W. Griffioen,et al.  Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1) , 2008, Angiogenesis.

[44]  S. Yamada,et al.  HMGB1, a novel inflammatory cytokine. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[45]  M. Nishibori,et al.  Mast cell tryptase stimulates DLD-1 carcinoma through prostaglandin- and MAP kinase-dependent manners. , 2005, Journal of pharmacological sciences.

[46]  S. Toda,et al.  Mast cells and angiogenesis , 2003, Microscopy research and technique.

[47]  J. Parkkinen,et al.  Amphoterin, the 30-kDa Protein in a Family of HMGl-type Polypeptides , 2001 .

[48]  A. Passaniti,et al.  A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[49]  H. Shepard,et al.  Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α , 1987, Nature.